Hansa Biopharma AB is a biopharmaceutical company based in Lund, Sweden, that develops enzyme-based medicines for people with rare immunological conditions. Its main product is an enzyme that breaks down immunoglobulin G antibodies, and the company also works on antibody-modulating therapies and diagnostics in transplantation and autoimmune disease. Its customers are hospital specialists and transplant centres, and its work centres on helping patients who need desensitisation before organ transplants or treatment for antibody-mediated disorders.
The shares are listed on the London Exchange in UK under the code 0RC7, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1846 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
68/100
Mixed trend against its averages.
See the numbers →
Above 200-day average9.6%
From 52-week high-19.2%
MomentumStrong
80/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return21.3%
6-month return57.9%
12-month, skipping last month8.5%
Stability (higher is calmer)Weak
22/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)66.2%
Worst drawdown, 1 year (smaller is calmer)-42.0%
LiquidityWeak
37/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.21M SEK
Zero-volume days16.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 23.57 – 48.00Daily closes, split-adjusted
Signals
50-day average38.70
200-day average34.23
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.27
Technical summary
Daily
Bullish
10 bullish · 1 neutral · 5 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
35.93
Bullish
EMA 10
36.13
Bullish
SMA 20
34.66
Bullish
EMA 20
36.01
Bullish
SMA 50
38.70
Bearish
EMA 50
36.75
Bullish
SMA 100
36.41
Bullish
EMA 100
36.19
Bullish
SMA 200
34.23
Bullish
EMA 200
34.79
Bullish
Oscillators (daily)
RSI (14)
55.52
Neutral
MACD (12, 26)
-0.23
Bearish
Momentum (12)
11.80
Bullish
Stochastic %K (14)
92.05
Bearish
Williams %R (14)
-7.95
Bearish
CCI (20)
113.6
Bearish
Pivot points (classic, last session)
S3
33.53
S2
34.32
S1
35.92
Pivot
36.71
R1
38.31
R2
39.10
R3
40.70
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
